De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course

被引：1

作者：

Ramachandran, Preethi ^{[1
]}

Sahni, Sonu ^{[1
]}

Wang, Jen C. ^{[1
]}

机构：

[1] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY 11212 USA

来源：

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS | 2019年 / 7卷

关键词：

DLBCL; gastrointestinal lymphoma; CD5+ lymphoma; B-cell lymphoma; small bowel lymphoma; CD5(+); EXPRESSION; TUMORS;

D O I：

10.1177/2324709619893546

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The gastrointestinal tract is a common extranodal site for lymphomas. However, primary gastrointestinal lymphomas are rare. Diffuse large B-cell lymphomas (DLBCL) are the most commonly encountered type in the gastrointestinal tract. Most of the DLBCL are CD5 negative. CD5+ DLBCL is very rare and a poor prognostic subtype of lymphoma. We report a rare case of primary small bowel CD5+ DLBCL that evolved from being a localized low International Prognostic Index-scored disease into an advanced and aggressive disease primarily dictated by the presence of CD5 antigen positivity.

引用

页数：5

共 50 条

[21] Primary Gastrointestinal Diffuse Large B-cell Lymphoma
Lodhi, Hanan T.
Hussain, Qulsoom
Munir, Ahmed
Zafar, Fahad
Khan, Zarak H.
CUREUS, 2018, 10 (09):
[22] Childhood de novo CD5+Diffuse Large B-cell Lymphoma: a Separate Entity?
Coffey, Amy
Allen, Ashleigh
Thomsen, Matthew B.
Sulis, Maria Luisa
Murty, Vundavalli
Hoehn, Daniela
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2015, 45 (05): : 574 - 581
[23] Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma
Kaneko, Hiroto
Shimura, Kazuho
Horiike, Shigeo
Kuroda, Junya
Matsumoto, Yosuke
Yokota, Shohei
Nishida, Koichi
Ohkawara, Yasuo
Taniwaki, Masafumi
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (04) : 346 - 350
[24] Clinical Features of De Novo CD25-Positive Diffuse Large B-Cell Lymphoma
Fujiwara, Shin-ichiro
Muroi, Kazuo
Hirata, Yuji
Sato, Kazuya
Matsuyama, Tomohiro
Ohmine, Ken
Suzuki, Takahiro
Ozaki, Katsutoshi
Mori, Masaki
Nagai, Tadashi
Ozawa, Keiya
BLOOD, 2011, 118 (21) : 1145 - 1145
[25] Primary adrenal de novo CD5-positive diffuse large B cell lymphoma
Armin Rashidi
Catherine W. Bergeron
Stephen I. Fisher
Ian A. Chen
Annals of Hematology, 2013, 92 : 1281 - 1282
[26] Primary adrenal de novo CD5-positive diffuse large B cell lymphoma
Rashidi, Armin
Bergeron, Catherine W.
Fisher, Stephen I.
Chen, Ian A.
ANNALS OF HEMATOLOGY, 2013, 92 (09) : 1281 - 1282
[27] CD5+ Diffuse Large B-Cell Lymphoma with c-myc/IgH Rearrangement Presenting as Primary Effusion Lymphoma
Shinya Fujisawa
Fumihiko Tanioka
Toshihiko Matsuoka
Takachika Ozawa
International Journal of Hematology, 2005, 81 : 315 - 318
[28] CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma
Fujisawa, S
Tanioka, F
Matsuoka, T
Ozawa, T
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (04) : 315 - 318
[29] De novo CD5+diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era
Hu, Bei
Nastoupil, Loretta J.
Loghavi, Sanam
Westin, Jason R.
Thakral, Beenu
Fayad, Luis E.
Hagemeister, Fredrick
Neelapu, Sattva
Samaniego, Felipe
Lee, Hun J.
Wang, Michael L.
Fanale, Michelle
Fowler, Nathan
Oki, Yasuhiro
LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 328 - 336
[30] CD5+ MYC+ predicts worse prognosis in diffuse large B-cell lymphoma
Lu, Ting-Xun
Wu, Shuang
Zhou, Xin-Yi
Zhang, Ying
Hong, Ting-Ting
Cai, Dong-Yan
Hua, Hai-Ying
Qi, Xiao-Wei
Wu, Xiao-Hong
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2020, 112

← 1 2 3 4 5 →